Solid Biosciences Inc. SLDB Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s accrued expenses and other liabilities?
- Solid Biosciences Inc. (SLDB) reported accrued expenses and other liabilities of -$473K in Q1 2026.
- How has Solid Biosciences Inc.'s accrued expenses and other liabilities changed year-over-year?
- Solid Biosciences Inc.'s accrued expenses and other liabilities decreased by 72.0% year-over-year, from -$275K to -$473K.